Insider Selling: 111 (NASDAQ:YI) Director Sells 44,000 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 44,000 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $0.23, for a total value of $10,120.00. Following the completion of the transaction, the director directly owned 495,462 shares in the company, valued at $113,956.26. The trade was a 8.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $11,481.60.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $388.80.

111 Stock Down 6.5%

YI stock opened at $4.57 on Tuesday. 111, Inc. Sponsored ADR has a twelve month low of $2.48 and a twelve month high of $11.17. The stock has a market cap of $40.17 million, a P/E ratio of -3.26 and a beta of 0.60. The business’s 50-day moving average price is $5.88 and its 200-day moving average price is $5.66.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.